Susquehanna Advisors Group »

Bridgebio Pharma shares owned by Susquehanna Advisors Group

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Susquehanna Advisors Group from 13F filings

Historical chart of Susquehanna Advisors Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Susquehanna Advisors Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Susquehanna Advisors Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $128k 7.5M 0.02

More positions owned by Susquehanna Advisors Group

Invesco Qqq Tr Unit Ser 1 (QQQ)
Pfizer (PFE)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Shopify Cl A Sub Vtg Shs (SHOP)
Oracle Corporation (ORCL)
Nike CL B (NKE)
Sea Sponsord Ads (SE)
Mastercard Incorporated Cl A (MA)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Nextnav Common Stock (NN)
Lumentum Hldgs Note 1.500%12/1 (Principal)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Strategy Cl A New Put Option (MSTR)
Nextera Energy Unit 02/15/2029 (NEE.PV)

View all positions for Susquehanna Advisors Group

Top funds holding Bridgebio Pharma

Linden Advisors
D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
Jump Financial
CSS
Alberta Investment Management Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Wellington Management Company
Calamos Advisors
Susquehanna Advisors Group
State Street Corporation

View all funds holding Bridgebio Pharma